Resultados de procura - Michael Derks

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome por Celia Goeldner, Priya S. Kishnani, Brian G. Skotko, Julián Lirio Casero, Joerg F. Hipp, Michael Derks, Maria‐Clemencia Hernandez, Omar Khwaja, Sian Lennon-Chrimes, Jana Noeldeke, Sabine Pellicer, Lisa Squassante, Jeannie Visootsak, Christoph Wandel, Paulo Fontoura, Xavier Liogier D’ardhuy, Rafael de la Torre, Paul Glue, Julie Hoover‐Fong, Sonja Uhlmann, Jorge Malagón Valdez, Andrew J. Marshall, Federico Martinón‐Torres, Lorenzo Redondo-Collazo, Carmen Rodríguez‐Tenreiro, Valeria Marquez Chin, Adriana G. Michel Reynoso, Ed Mitchell, Rebecca F. Slykerman, Trecia A. Wouldes, Sarah Loveday, Fernando Moldenhauer, Ramón Novell, César Ochoa, Michael S. Rafii, Anne‐Sophie Rebillat, Damien Sanlaville, Pierre Sarda, Rohit Shankar, Margaret B. Pulsifer, Casey L. Evans, Alexandra M. Silva, Mary Ellen McDonough, Maria A. Stanley, Lindsay M. McCary, Stefano Vicari, William R. Wilcox, Giuseppe Zampino, Alessandro Zuddas